Clinical Trial Update: A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])

View source ↗

Summary

A completed study assessed eligibility criteria for the CAH-301 gene therapy in classic congenital adrenal hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• CAH-301

Snippet

Sponsor: Adrenas Therapeutics Inc | Conditions: Congenital Adrenal Hyperplasia | Status: COMPLETED